Summary of the NACI Statement on Public Health Level Recommendations on the Use of Pneumococcal Vaccines in Adults, Including the Use of 15-valent and 20-valent Conjugate Vaccines. [PDF]
Wierzbowski A, Pless R, Hildebrand KJ.
europepmc +1 more source
Willingness of Caregivers to Have Their Children Vaccinated with Pneumococcal Vaccines in the Context of an Innovative Immunization Strategy - Weifang City, Shandong Province, 2021. [PDF]
Yang Y +12 more
europepmc +1 more source
Quantitative Methods for Evaluating Antibody Responses to Pneumococcal Vaccines: A Scoping Review. [PDF]
Hayashi Y, Domai FM, Dhoubhadel BG.
europepmc +1 more source
Immunogenicity and Safety of Pneumococcal Vaccines Co-Administered with Common Travel Vaccines in Adults: A Systematic Review. [PDF]
Niyati R +4 more
europepmc +1 more source
Multi-Valent Protein Hybrid Pneumococcal Vaccines: A Strategy for the Next Generation of Vaccines. [PDF]
Scott NR +3 more
europepmc +1 more source
Summary of the National Advisory Committee on Immunization (NACI) Statement: Recommendations on the use of pneumococcal vaccines in adults, including Pneu-C-21. [PDF]
Wong E +3 more
europepmc +1 more source
Incidence, aetiology and serotype coverage for pneumococcal vaccines of community-acquired pneumonia in adults: a population-based prospective active surveillance study in Brazil. [PDF]
Duarte FG +10 more
europepmc +1 more source
Open-label, randomised controlled, multicentre study evaluating higher valency pneumococcal vaccines (PCV15/PCV20) compared with PCV13 given in homologous schedules at 3 months and 12 months ('1+1' schedule) and 2 months, 4 months and 12 months ('2+1' schedule) in infants: protocol. [PDF]
Aslam R +19 more
europepmc +1 more source
Influenza and pneumococcal vaccines uptake among pharmacists: systematic review and meta-analysis. [PDF]
Waszkiewicz M +3 more
europepmc +1 more source

